What are the major opportunities in the Neurogenic Detrusor Overactivity market? What are the strategies for the Neurogenic Detrusor Overactivity market?

For detailed insights on the major opportunities and strategies in the Neurogenic Detrusor Overactivity market, Read More

How does the Neurogenic Detrusor Overactivity market relate to the overall economy and other similar markets?

For detailed insights on Neurogenic Detrusor Overactivity's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Neurogenic Detrusor Overactivity market growth? SWOT analysis of the Neurogenic Detrusor Overactivity market.

For detailed insights on the key dynamics influencing the Neurogenic Detrusor Overactivity market growth and SWOT analysis of the Neurogenic Detrusor Overactivity industry, Read More

Global Neurogenic Detrusor Overactivity Market Report 2025

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Neurogenic Detrusor Overactivity Global Market Report 2025

Name: Neurogenic Detrusor Overactivity Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Types (Non-Surgical Treatment, Surgical Treatment, Follow-Up Treatment), By Application (Adult, Child), By End-User (Hospitals, Urology Clinics, Rehabilitation Centers, Private Practices, Long-Term Care Facilities) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Neurogenic Detrusor Overactivity Market?

Neurogenic detrusor overactivity (NDO) is a bladder dysfunction caused by neurological conditions that disrupt the normal nerve signals between the brain, spinal cord, and the detrusor muscle of the bladder. This disruption leads to increased or involuntary contractions of the detrusor muscle, resulting in symptoms such as urinary urgency, frequency, urge incontinence, and sometimes incomplete bladder emptying.

The main treatment types for neurogenic detrusor overactivity (NDO) include non-surgical treatment, surgical treatment, and follow-up treatment. Non-surgical treatment refers to medical care or therapies that manage or cure a condition without the need for invasive surgical procedures. These treatments are used for different applications, including adults and children, for varied end-users such as hospitals, urology clinics, rehabilitation centers, private practices, and long-term care facilities.

Neurogenic Detrusor Overactivity Market Size and growth rate 2025 to 2029: Graph

What Is The Neurogenic Detrusor Overactivity Market Size 2025 And Growth Rate?

The neurogenic detrusor overactivity market size has grown strongly in recent years. It will grow from $1.69 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, rising awareness among healthcare professionals, growing adoption of pharmaceutical interventions, expansion of hospital and clinic infrastructure, and increasing diagnosis rates.

What Is The Neurogenic Detrusor Overactivity Market Growth Forecast?

The neurogenic detrusor overactivity market size is expected to see strong growth in the next few years. It will grow to $2.45 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to a rising aging population, a growing prevalence of spinal cord injuries, increasing healthcare expenditure, expansion of minimally invasive treatment options, and rising patient awareness and education. Major trends in the forecast period include technology advancements in stem cell approaches, innovations in drug delivery systems, developments in neuromodulation devices, research and development in personalized medicine, and advancements in minimally invasive procedures.

Book your 30 minutes free consultation with our research experts

How Is The Neurogenic Detrusor Overactivity Market Segmented?

The neurogenic detrusor overactivity market covered in this report is segmented –

1) By Types: Non-Surgical Treatment, Surgical Treatment, Follow-Up Treatment

2) By Application: Adult, Child

3) By End-User: Hospitals, Urology Clinics, Rehabilitation Centers, Private Practices, Long-Term Care Facilities

Subsegments:

1) By Non-Surgical Treatment: Antimuscarinic Drugs, Beta-3 Adrenergic Agonists, behavioral therapy, Neuromodulation, Clean Intermittent Catheterization, Intravesical Therapies

2) By Surgical Treatment: Botulinum Toxin Injection, Augmentation Cystoplasty, Urinary Diversion, External Sphincterotomy, Artificial Urinary Sphincter Implantation

3) By Follow-Up Treatment: Urodynamic Evaluation, Ultrasound Monitoring, Laboratory Tests, Ongoing Catheterization, Repeat Botulinum Toxin Injections, Patient and Caregiver Training, Quality of Life Assessment

What Is Driving The Neurogenic Detrusor Overactivity Market? Rising Incidence Of Neurological Disorders Drives Growth Of Market Due To Higher Demand For Effective Bladder Dysfunction Treatments

The rising incidence of neurological disorders is expected to propel the growth of the neurogenic detrusor overactivity market going forward. Neurological disorders refer to medical conditions that affect the brain, spinal cord, or nerves, leading to problems with movement, sensation, cognition, or other bodily functions. Neurological disorders are rising as people are living longer, which increases the chances of age-related brain degeneration. Neurogenic detrusor overactivity (NDO) is a bladder dysfunction commonly associated with neurological disorders, such as spinal cord injury, multiple sclerosis, and Parkinson’s disease. These conditions disrupt normal nerve signaling between the brain and bladder, leading to involuntary bladder contractions. For instance, in April 2024, according to a study published by the American Academy of Neurology (AAN), a US-based neurology and neuroscience organization, there will be an estimated 4.9 billion cases of brain disorders globally by 2050, a 22% increase from approximately 4 billion cases in 2021. Therefore, the rising incidence of neurological disorders is driving growth in the neurogenic detrusor overactivity market.

Who Are The Major Players In The Global Neurogenic Detrusor Overactivity Market?

Major companies operating in the neurogenic detrusor overactivity market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi S. A., Medtronic plc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Intas Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries, Apotex Inc., Viatris Inc., Sumitomo Pharma America Inc., Galderma, Ipsen, Coloplast A/S, Aurobindo Pharma Limited, Hisamitsu Pharmaceutical Co. Inc., Kaken Pharmaceutical Co. Ltd., Hugel Inc.

What Are The Key Trends Of The Global Neurogenic Detrusor Overactivity Market? Advanced Generic Therapies Improving Pediatric NDO Treatment Outcomes

Major companies operating in the neurogenic detrusor overactivity (NDO) treatment market are focusing on developing advanced generic therapeutics such as beta-3 adrenergic receptor agonists to deliver effective bladder control solutions at reduced costs. Beta-3 adrenergic receptor agonists, such as mirabegron, function by relaxing the detrusor muscle in the bladder, thereby increasing bladder capacity and reducing symptoms such as urgency and incontinence. For instance, in April 2024, Lupin Ltd., an India-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (USFDA) to launch Mirabegron, the generic version of Myrbetriq, in the United States. As an advanced once-daily oral therapy, Mirabegron offers a convenient and effective treatment option for patients with overactive bladder (OAB) and neurogenic detrusor overactivity (NDO) in pediatric populations. This approval reinforces Lupin’s commitment to expanding access to high-quality, affordable generic medications in critical therapeutic areas.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Neurogenic Detrusor Overactivity Market? Boston Scientific Acquired Axonics To Expand Neuromodulation And Urology Portfolio

In November 2024, Boston Scientific Corporation, a US-based medical device company, acquired Axonics, Inc. for an undisclosed amount. Through this acquisition, Boston Scientific aims to broaden its neuromodulation and urology offerings by incorporating Axonics' advanced sacral neuromodulation technologies, strengthen its position in treating patients with overactive bladder and other urinary and bowel dysfunctions, and enhance its ability to deliver comprehensive solutions for pelvic health conditions. Axonics Inc. is a US-based medical technology company that provides sacral neuromodulation (SNM) systems that improve the control of an overactive bladder.

What Is The Regional Outlook For The Global Neurogenic Detrusor Overactivity Market?

North America was the largest region in the neurogenic detrusor overactivity market in 2024. The regions covered in the neurogenic detrusor overactivity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurogenic detrusor overactivity market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neurogenic Detrusor Overactivity Market?

The neurogenic detrusor overactivity market includes revenues earned by entities by providing services such as medication management, behavioral and lifestyle interventions, physiotherapy, absorbent products and skin care, and catheterization. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Neurogenic Detrusor Overactivity Industry?

The neurogenic detrusor overactivity market research report is one of a series of new reports from The Business Research Company that provides neurogenic detrusor overactivity market statistics, including the neurogenic detrusor overactivity industry global market size, regional shares, competitors with the neurogenic detrusor overactivity market share, detailed neurogenic detrusor overactivity market segments, market trends, and opportunities, and any further data you may need to thrive in the neurogenic detrusor overactivity industry. These neurogenic detrusor overactivity market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Neurogenic Detrusor Overactivity Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.82 billion
Revenue Forecast In 2034	$2.45 billion
Growth Rate	CAGR of 7.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The neurogenic detrusor overactivity market covered in this report is segmented – 1) By Types: Non-Surgical Treatment, Surgical Treatment, Follow-Up Treatment 2) By Application: Adult, Child 3) By End-User: Hospitals, Urology Clinics, Rehabilitation Centers, Private Practices, Long-Term Care Facilities Subsegments: 1) By Non-Surgical Treatment: Antimuscarinic Drugs, Beta-3 Adrenergic Agonists, Behavioral Therapy, Neuromodulation, Clean Intermittent Catheterization, Intravesical Therapies 2) By Surgical Treatment: Botulinum Toxin Injection, Augmentation Cystoplasty, Urinary Diversion, External Sphincterotomy, Artificial Urinary Sphincter Implantation 3) By Follow-Up Treatment: Urodynamic Evaluation, Ultrasound Monitoring, Laboratory Tests, Ongoing Catheterization, Repeat Botulinum Toxin Injections, Patient and Caregiver Training, Quality of Life Assessment
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi S. A., Medtronic plc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Intas Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries, Apotex Inc., Viatris Inc., Sumitomo Pharma America Inc., Galderma, Ipsen, Coloplast A/S, Aurobindo Pharma Limited, Hisamitsu Pharmaceutical Co. Inc., Kaken Pharmaceutical Co. Ltd., Hugel Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Neurogenic Detrusor Overactivity Market Characteristics

3. Neurogenic Detrusor Overactivity Market Trends And Strategies

4. Neurogenic Detrusor Overactivity Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Neurogenic Detrusor Overactivity Growth Analysis And Strategic Analysis Framework

5.1. Global Neurogenic Detrusor Overactivity PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Neurogenic Detrusor Overactivity Market Growth Rate Analysis

5.4. Global Neurogenic Detrusor Overactivity Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Neurogenic Detrusor Overactivity Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Neurogenic Detrusor Overactivity Total Addressable Market (TAM)

6. Neurogenic Detrusor Overactivity Market Segmentation

6.1. Global Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Non-Surgical Treatment

Surgical Treatment

Follow-Up Treatment

6.2. Global Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adult

Child

6.3. Global Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Urology Clinics

Rehabilitation Centers

Private Practices

Long-Term Care Facilities

6.4. Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Non-Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antimuscarinic Drugs

Beta-3 Adrenergic Agonists

Behavioral Therapy

Neuromodulation

Clean Intermittent Catheterization

Intravesical Therapies

6.5. Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Botulinum Toxin Injection

Augmentation Cystoplasty

Urinary Diversion

External Sphincterotomy

Artificial Urinary Sphincter Implantation

6.6. Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Follow-Up Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Urodynamic Evaluation

Ultrasound Monitoring

Laboratory Tests

Ongoing Catheterization

Repeat Botulinum Toxin Injections

Patient and Caregiver Training

Quality of Life Assessment

7. Neurogenic Detrusor Overactivity Market Regional And Country Analysis

7.1. Global Neurogenic Detrusor Overactivity Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Neurogenic Detrusor Overactivity Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurogenic Detrusor Overactivity Market

8.1. Asia-Pacific Neurogenic Detrusor Overactivity Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurogenic Detrusor Overactivity Market

9.1. China Neurogenic Detrusor Overactivity Market Overview

9.2. China Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurogenic Detrusor Overactivity Market

10.1. India Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurogenic Detrusor Overactivity Market

11.1. Japan Neurogenic Detrusor Overactivity Market Overview

11.2. Japan Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurogenic Detrusor Overactivity Market

12.1. Australia Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurogenic Detrusor Overactivity Market

13.1. Indonesia Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurogenic Detrusor Overactivity Market

14.1. South Korea Neurogenic Detrusor Overactivity Market Overview

14.2. South Korea Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurogenic Detrusor Overactivity Market

15.1. Western Europe Neurogenic Detrusor Overactivity Market Overview

15.2. Western Europe Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurogenic Detrusor Overactivity Market

16.1. UK Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurogenic Detrusor Overactivity Market

17.1. Germany Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurogenic Detrusor Overactivity Market

18.1. France Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurogenic Detrusor Overactivity Market

19.1. Italy Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurogenic Detrusor Overactivity Market

20.1. Spain Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurogenic Detrusor Overactivity Market

21.1. Eastern Europe Neurogenic Detrusor Overactivity Market Overview

21.2. Eastern Europe Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurogenic Detrusor Overactivity Market

22.1. Russia Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurogenic Detrusor Overactivity Market

23.1. North America Neurogenic Detrusor Overactivity Market Overview

23.2. North America Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurogenic Detrusor Overactivity Market

24.1. USA Neurogenic Detrusor Overactivity Market Overview

24.2. USA Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurogenic Detrusor Overactivity Market

25.1. Canada Neurogenic Detrusor Overactivity Market Overview

25.2. Canada Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurogenic Detrusor Overactivity Market

26.1. South America Neurogenic Detrusor Overactivity Market Overview

26.2. South America Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurogenic Detrusor Overactivity Market

27.1. Brazil Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurogenic Detrusor Overactivity Market

28.1. Middle East Neurogenic Detrusor Overactivity Market Overview

28.2. Middle East Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurogenic Detrusor Overactivity Market

29.1. Africa Neurogenic Detrusor Overactivity Market Overview

29.2. Africa Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurogenic Detrusor Overactivity Market Competitive Landscape And Company Profiles

30.1. Neurogenic Detrusor Overactivity Market Competitive Landscape

30.2. Neurogenic Detrusor Overactivity Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi S. A. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Neurogenic Detrusor Overactivity Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd.

31.2. Astellas Pharma Inc.

31.3. Intas Pharmaceuticals Ltd.

31.4. Macleods Pharmaceuticals Ltd.

31.5. Sun Pharmaceutical Industries

31.6. Apotex Inc.

31.7. Viatris Inc.

31.8. Sumitomo Pharma America Inc.

31.9. Galderma

31.10. Ipsen

31.11. Coloplast A/S

31.12. Aurobindo Pharma Limited

31.13. Hisamitsu Pharmaceutical Co. Inc.

31.14. Kaken Pharmaceutical Co. Ltd.

31.15. Hugel Inc.

32. Global Neurogenic Detrusor Overactivity Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurogenic Detrusor Overactivity Market

34. Recent Developments In The Neurogenic Detrusor Overactivity Market

35. Neurogenic Detrusor Overactivity Market High Potential Countries, Segments and Strategies

35.1 Neurogenic Detrusor Overactivity Market In 2029 - Countries Offering Most New Opportunities

35.2 Neurogenic Detrusor Overactivity Market In 2029 - Segments Offering Most New Opportunities

35.3 Neurogenic Detrusor Overactivity Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Non-Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Follow-Up Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Neurogenic Detrusor Overactivity Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Neurogenic Detrusor Overactivity Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Pfizer Inc. Financial Performance

Table 78: Johnson & Johnson Services Inc. Financial Performance

Table 79: AbbVie Inc. Financial Performance

Table 80: Sanofi S. A. Financial Performance

Table 81: Medtronic plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Non-Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Neurogenic Detrusor Overactivity Market, Sub-Segmentation Of Follow-Up Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Neurogenic Detrusor Overactivity Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Neurogenic Detrusor Overactivity Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Neurogenic Detrusor Overactivity Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Neurogenic Detrusor Overactivity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Neurogenic Detrusor Overactivity Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Pfizer Inc. Financial Performance

Figure 78: Johnson & Johnson Services Inc. Financial Performance

Figure 79: AbbVie Inc. Financial Performance

Figure 80: Sanofi S. A. Financial Performance

Figure 81: Medtronic plc Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Peripheral Neuropathy Global Market Report 2025 – By Type (Chemotherapy-Induced, Diabetic, Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS Associated, Idiopathic), By Diagnosis (Blood Test,...

Neurotoxin Global Market Report 2025 – By Product Type (Botox, Dysport, Xeomin, Other Products), By Application (Therapeutic, Aesthetic), By End User (Hospitals, Specialty Clinics, Dermatology Clinics, Other End Users) –...

Diabetic Neuropathy Global Market Report 2025 – By Disorder (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy), By Drug Class (Analgesics, Anti-Depressants, Anti-convulsant, Other Drug C...

Neuromodulation Global Market Report 2025 – By Technology (Internal Neuromodulation, External Neuromodulation (Non-invasive)), By Biomaterial (Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial), By Applica...

Neurotrophic Keratitis Treatment Global Market Report 2025 – By Treatment (Topical Antibiotics, Recombinant Human Nerve Growth Factor (rhNGF), Amniotic Membrane Transplantation, Keratoplasty, Other Treatments), By Route ...

Brain Health Supplements Global Market Report 2025 – By Product (Natural Molecules, Herbal Extract, Vitamins and Minerals), By Supplement Form (Tablets, Capsules, Liquid), By Distribution (Supermarket and Hypermarket, Dr...

Generic Central Nervous System Drugs Global Market Report 2025 – By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other Types), By Drug C...

Frequently Asked Questions

What is the definition of the Neurogenic Detrusor Overactivity market?

How will the Neurogenic Detrusor Overactivity market drivers and restraints affect the market dynamics? What forces will shape the Neurogenic Detrusor Overactivity industry going forward?

The Neurogenic Detrusor Overactivity market major growth driver - Rising Incidence Of Neurological Disorders Drives Growth Of Market Due To Higher Demand For Effective Bladder Dysfunction Treatments. For further insights on the Neurogenic Detrusor Overactivity market, request a sample here

What is the forecast market size or the forecast market value of the Neurogenic Detrusor Overactivity market?

The Neurogenic Detrusor Overactivity market size has grown strongly in recent years. The neurogenic detrusor overactivity market size has grown strongly in recent years. It will grow from $1.69 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, rising awareness among healthcare professionals, growing adoption of pharmaceutical interventions, expansion of hospital and clinic infrastructure, and increasing diagnosis rates. The neurogenic detrusor overactivity market size is expected to see strong growth in the next few years. It will grow to $2.45 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to a rising aging population, a growing prevalence of spinal cord injuries, increasing healthcare expenditure, expansion of minimally invasive treatment options, and rising patient awareness and education. Major trends in the forecast period include technology advancements in stem cell approaches, innovations in drug delivery systems, developments in neuromodulation devices, research and development in personalized medicine, and advancements in minimally invasive procedures. For further insights on the Neurogenic Detrusor Overactivity market, request a sample here

How is the Neurogenic Detrusor Overactivity market segmented?

The neurogenic detrusor overactivity market covered in this report is segmented –
1) By Types: Non-Surgical Treatment, Surgical Treatment, Follow-Up Treatment
2) By Application: Adult, Child
3) By End-User: Hospitals, Urology Clinics, Rehabilitation Centers, Private Practices, Long-Term Care Facilities

Subsegments:
1) By Non-Surgical Treatment: Antimuscarinic Drugs, Beta-3 Adrenergic Agonists, Behavioral Therapy, Neuromodulation, Clean Intermittent Catheterization, Intravesical Therapies
2) By Surgical Treatment: Botulinum Toxin Injection, Augmentation Cystoplasty, Urinary Diversion, External Sphincterotomy, Artificial Urinary Sphincter Implantation
3) By Follow-Up Treatment: Urodynamic Evaluation, Ultrasound Monitoring, Laboratory Tests, Ongoing Catheterization, Repeat Botulinum Toxin Injections, Patient and Caregiver Training, Quality of Life Assessment For further insights on the Neurogenic Detrusor Overactivity market, request a sample here

Which region has the largest share of the Neurogenic Detrusor Overactivity market? What are the other regions covered in the report?

Who are the major players in the Neurogenic Detrusor Overactivity market?

What are the key trends in the Neurogenic Detrusor Overactivity market?

Major trends in the Neurogenic Detrusor Overactivity market include Advanced Generic Therapies Improving Pediatric NDO Treatment Outcomes. For further insights on the Neurogenic Detrusor Overactivity market, request a sample here.